Recalls / Active ingredient / Docetaxel
Docetaxel
4 FDA drug recalls involving the active ingredient “Docetaxel”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2020-12-08 | Class II | Docetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial, C | Shilpa Medicare Limited |
| 2019-03-06 | Class II | Docetaxel Injection USP, 80 mg/4 mL, (20 mg/mL), One-Vial Formulation, Rx only, Mfd By: Dr. Reddy's Laboratori | Dr. Reddy's Laboratories, Inc. |
| 2018-04-27 | Class II | Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. | Sanofi-Aventis U.S. LLC |
| 2017-01-09 | Class II | Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, V | Dr. Reddy's Laboratories, Inc. |